# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-022658
Filing Date
2024-05-10
Accepted
2024-05-10 16:37:48
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cpix-20240331.htm iXBRL | 10-Q | 653147
2 | EX-10.6 | a2024q1-exhibit106.htm | EX-10.6 | 41701
3 | EX-31.1 | a2024q1-exhibit311.htm | EX-31.1 | 12672
4 | EX-31.2 | a2024q1-exhibit312.htm | EX-31.2 | 12665
5 | EX-32.1 | a2024q1-exhibit321.htm | EX-32.1 | 6870
| Complete submission text file | 0001628280-24-022658.txt |  | 4190810

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20240331.xsd | EX-101.SCH | 33420
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20240331_cal.xml | EX-101.CAL | 49343
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20240331_def.xml | EX-101.DEF | 125942
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20240331_lab.xml | EX-101.LAB | 447903
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20240331_pre.xml | EX-101.PRE | 301386
63 | EXTRACTED XBRL INSTANCE DOCUMENT | cpix-20240331_htm.xml | XML | 396961

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 24935570
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)